With the notable exception of Monsanto’s billion-dollar acquisition of Climate Corp more than a decade ago, category-defining exits have proved elusive in agtech, which has returned little capital to date. But could 2026 be the year everything changes?
Probably not, says PJ Amini, VP ag investments at Bayer’s corporate venture arm Leaps by Bayer, although he senses a shift from an era of “reckonin...
The strongest version of this narrative presents agtech as a sector on the cusp of transformation, with profitability and strategic realignment finally within reach. Amini’s perspective is grounded in Bayer’s corporate strategy, emphasizing patience and realistic expectations—favoring "zebras" over "unicorns." This framing acknowledges past disappointments while offering cautious optimism, a reasonable stance given the sector’s history of overhyped valuations and limited exits.
However, the narr...